Scientific Facts
Research and Trial Data.
What Microbiology Tells Us
The Scientific FACTS
Human Trial Data
Sarasota
Dr. Michael Swor-PI
IRB-Approved Trial (2016) N=5
- Moderate to Severe Infections
- FDA criteria for DX and F/U 5
- Clinical Cures/No rescue medication
- Faster symptom resolution than drugs
- One with BV/VVC*
Boynton Beach
Dr. Keith Aqua-PI
Investigator-Initiated Trial (2021) N=6
- FDA criteria for DX and F/U
- Three had VVC alone
- One had VVC/AV*
- One had VVC/AV/BV
- One had BV/AV
- 6 clinical cures for all conditions/no rescue medication
- 2 mycologic cures for Candida
Total: 30 Cures
19 More Users Cured
13 of those were MD/NP/PhD-Observed
One had BV with VVC-CURED
VVC is Vulvovaginal Candidiasis
BV is Bacterial Vaginosis
AV is Aerobic Vaginitis
Importance of Mouse Data
*ALL drugs tested in the mouse model FAILED due to pH, favoring infection
Two studies in mice (2018) were conducted at LSU (PhD Experts in VVC) Results establish:
- The mechanism of action
- Proof of cooling efficacy
Results
- Statistically Significant reduction in inflammation (PMNs) or white blood cells: the immune response
- Statistically Significant reduction in infection (Hyphae)
- ‘p‘ values less than 0.05 are statistically significant
Decreased Infection p=0.0002
Decreased Inflammation p=0.0033